ARKG基因组革命投资追踪
ARKG基因组革命投资追踪
数据来源:官网 ARKG 是凯瑟琳伍德管理的交易所交易基金(ETF),主要投资于基因组学领域的股票。“ARK基因革命基金交易分享大师号”基于ARKG的每日披露调仓报告,帮助投资者追踪其投资策略。
IP属地:未知
0关注
1475粉丝
0主题
0勋章
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 173,285 shares, the number of shares held increased 1.41% compared to the previous period and now represents 6.17% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 326,350 shares, the number of shares held increased 3.03% compared to the previous period and now represents 1.65% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 339,650 shares, the number of shares held increased 3.03% compared to the previous period and now represents 6.91% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 404,736 shares, the number of shares held decreased 3.71% compared to the previous period and now represents 1.45% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 13,320 shares, the number of shares held decreased 0.98% compared to the previous period and now represents 4.26% of the total position.
ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 17,652 shares, the number of shares held increased 0.62% compared to the previous period and now represents 3.6% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 2,102 shares, the number of shares held decreased 0.11% compared to the previous period and now represents 4.32% of the total position.
ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 532 shares, the number of shares held increased 4.07% compared to the previous period and now represents 0.86% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 261,340 shares, the number of shares held decreased 2.11% compared to the previous period and now represents 1.62% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 25,784 shares, the number of shares held increased 0.22% compared to the previous period and now represents 7.57% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 38,235 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 6.34% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 12,873 shares, the number of shares held decreased 0.66% compared to the previous period and now represents 4.26% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 274,134 shares, the number of shares held increased 2.61% compared to the previous period and now represents 1.52% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 244,867 shares, the number of shares held decreased 2.11% compared to the previous period and now represents 7.3% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 89,915 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 7.46% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 112,816 shares, the number of shares held increased 0.85% compared to the previous period and now represents 1.62% of the total position.
ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 350 shares, the number of shares held increased 2.91% compared to the previous period and now represents 0.64% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 192,675 shares, the number of shares held increased 1.62% compared to the previous period and now represents 7.51% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 119 shares, the number of shares held decreased 0.099% compared to the previous period and now represents 2.21% of the total position.
ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 24,330 shares, the number of shares held increased 1.13% compared to the previous period and now represents 4.62% of the total position.

去老虎APP查看更多动态